Total Synthesis of 7-Ethyl-10-hydroxycamptothecin (SN38) and its Application to the Development of C18-Functionalized Camptothecin Derivatives

被引:15
|
作者
Yao, Yuan-Shan [2 ,3 ]
Liu, Jia-Li [1 ]
Xi, Jie [2 ]
Miu, Bukeyan [2 ]
Liu, Guai-Sai [2 ]
Wang, Shaozhong [2 ]
Meng, Linghua [1 ]
Yao, Zhu-Jun [2 ]
机构
[1] Chinese Acad Sci, Div Antitumor Pharmacol, State Key Lab Drug Res, Shanghai Inst Mat Med, Shanghai 201203, Peoples R China
[2] Nanjing Univ, State Key Lab Coordinat Chem, Nanjing Natl Lab Microstruct, Inst Chem Biol & Drug Innovat,Sch Chem & Chem Eng, Nanjing 210093, Jiangsu, Peoples R China
[3] Univ Sci & Technol China, Joint Lab Green Chem, Dept Chem, Hefei 230026, Anhui, Peoples R China
关键词
antitumor agents; camptothecin derivatives; Diels-Alder reaction; structure-activity relationships; total synthesis; PLANT ANTITUMOR AGENTS; IN-VITRO CYTOTOXICITY; ASYMMETRIC-SYNTHESIS; EFFICIENT; RING; (+)-CAMPTOTHECIN; CYCLIZATION; IRINOTECAN; INHIBITOR; CANCER;
D O I
10.1002/chem.201101389
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
A new chemical synthesis of SN38, the active metabolite of the camptothecin prodrug irinotecan, has been achieved in 12 steps from simple, commercially available starting materials. A mild and efficient FeCl3-catalyzed Friedlander condensation was successfully applied to construct the AB ring system. Functionalization of the C ring was accomplished by a vinylogous Mukaiyama reaction of an in situ generated N-acyliminium intermediate with a silyl enol ether. An intramolecular oxa Diels-Alder reaction efficiently constructed the D and E rings in one step. Successive asymmetric dihydroxylation and I-2-based hemiacetal oxidation furnished the stereo-chemistry of SN38 with high enantiopurity. Utilizing the ABC-ring intermediate and a functionalized silyl enol ether permitted the synthesis of a number of new C18-functionalized SN38 derivatives. Several of the novel SN38 derivatives that bore a C10 methoxy group were found to exhibit comparable or more potent inhibitory activity against the proliferation of cancer cells relative to SN38.
引用
收藏
页码:10462 / 10469
页数:8
相关论文
共 46 条
  • [1] Redox responsive 7-ethyl-10-hydroxycamptothecin (SN38) lysophospholipid conjugate: synthesis, assembly and anticancer evaluation
    He, Wei
    Du, Yawei
    Wang, Tao
    Wang, Ji
    Cheng, Lei
    Li, Xinsong
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2021, 606
  • [2] Human Serum Albumin Conjugates of 7-Ethyl-10-hydroxycamptothecin (SN38) for Cancer Treatment
    Sepehri, Nima
    Rouhani, Hasti
    Ghanbarpour, Ahmad Reza
    Gharghabi, Mehdi
    Tavassolian, Faranak
    Amini, Mohsen
    Ostad, Seyed Nasser
    Ghahremani, Mohammad Hossein
    Dinarvand, Rassoul
    [J]. BIOMED RESEARCH INTERNATIONAL, 2014, 2014
  • [3] Solid lipid nanoparticles containing 7-ethyl-10-hydroxycamptothecin (SN38): Preparation, characterization, in vitro, and in vivo evaluations
    Mosallaei, Navid
    Mahmoudi, Asma
    Ghandehari, Hamidreza
    Yellepeddi, Venkata Kashyap
    Jaafari, Mahmoud Reza
    Malaekeh-Nikouei, Bizhan
    [J]. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2016, 104 : 42 - 50
  • [4] Antibody Conjugates of 7-Ethyl-10-hydroxycamptothecin (SN-38) for Targeted Cancer Chemotherapy
    Moon, Sung-Ju
    Govindan, Serengulam V.
    Cardillo, Thomas M.
    D'Souza, Christopher A.
    Hansen, Hans J.
    Goldenberg, David M.
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (21) : 6916 - 6926
  • [5] ABCG2 mediates differential resistance to SN-38 (7-ethyl-10-hydroxycamptothecin) and homocamptothecins
    Bates, SE
    Medina-Pérez, WY
    Kohlhagen, G
    Antony, S
    Nadjem, T
    Robey, RW
    Pommier, Y
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2004, 310 (02): : 836 - 842
  • [6] SYNTHESIS AND ANTITUMOR-ACTIVITY OF 20(S)-CAMPTOTHECIN DERIVATIVES - CARBAMATE-LINKED, WATER-SOLUBLE DERIVATIVES OF 7-ETHYL-10-HYDROXYCAMPTOTHECIN
    SAWADA, S
    OKAJIMA, S
    AIYAMA, R
    NOKATA, K
    FURUTA, T
    YOKOKURA, T
    SUGINO, E
    YAMAGUCHI, K
    MIYASAKA, T
    [J]. CHEMICAL & PHARMACEUTICAL BULLETIN, 1991, 39 (06) : 1446 - 1454
  • [7] Conversion of irinotecan (CPT-11) to its active metabolite, 7-ethyl-10-hydroxycamptothecin (SN-38), by human liver carboxylesterase
    Rivory, LP
    Bowles, MR
    Robert, J
    Pond, SM
    [J]. BIOCHEMICAL PHARMACOLOGY, 1996, 52 (07) : 1103 - 1111
  • [8] Polymeric micelles loaded with 7-ethyl-10-hydroxy camptothecin (SN38) as effective antitumor nanoformulation
    Hu, Shiqi
    Shen, Youqing
    [J]. NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE, 2016, 12 (02) : 462 - 463
  • [9] A convergent fabrication of 7-ethyl-10-hydroxycamptothecin (SN-38)-loaded cobalt ferrite nanocarrier delivery for lung treatment
    Yang, Yu
    Alahmadi, Tahani Awad
    Alharbi, Sulaiman Ali
    Wainwright, Milton
    [J]. MATERIALS EXPRESS, 2023, 13 (05) : 829 - 838
  • [10] Plasma pharmacokinetics of 7-ethyl-10-hydroxycamptothecin (SN-38) after intravenous administration of SN-38 and irinotecan (CPT-11) to rats
    Kaneda, N
    Hosokawa, Y
    Yokokura, T
    Awazu, S
    [J]. BIOLOGICAL & PHARMACEUTICAL BULLETIN, 1997, 20 (09) : 992 - 996